In memoriam of Iván Lásló Bonta (1922-2007) by Zijlstra, F.J. (Freek)
Hindawi Publishing Corporation
Mediators of Inflammation
Volume 2007, Article ID 38283, 2 pages
doi:10.1155/2007/38283
Editorial
In Memoriam of Iva´n La´slo´ Bonta (1922–2007)
Freek J. Zijlstra
Department of Anesthesiology, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands
Received 20 February 2007; Accepted 20 February 2007
Copyright © 2007 Freek J. Zijlstra. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Professor Emeritus Iva´n La´slo´ Bonta, an internationally re-
nowned pharmacologist, died in Rome, Italy, on 6 February
2007, at age 84, on the verge of boarding an airplane to Israel.
His death is mourned by his family, many colleagues, friends,
and former students.
Iva´n was born on 6 October 1922 in Budapest, Hungary.
Due to antisemitic laws, after his grammar school, he was
not permitted to pursue medical studies. He survived the
2nd World War in a forced labour camp in Poland. There-
after, he studied medical science in Budapest and gradu-
ated in 1950. He became a doctoral student and obtained
his Ph.D. degree in experimental pharmacology, at a re-
search institute of the Hungarian Army. In 1947, he mar-
ried Vera. In the early 1950s, his son Janos and daugh-
ter Zsoka were born. In 1956, following the Russian sup-
pression of the Hungarians, the family decided to leave
Hungary and moved to the Netherlands, where he be-
came Head of Pharmacology Research at the drug company
Organon.
After successful research activities at Organon, in 1969
he was appointed Professor and Chairman at the Depart-
ment of Pharmacology of the Medical School of the Eras-
mus University Rotterdam. In 1992, he retired from the chair,
quite reluctantly at the age of 70 years. Prior to his retire-
ment, in 1991 he founded the international scientific jour-
nal Mediators of Inflammation (Rapid Communications of
Oxford Ltd.), of which the first bimonthly issue was pub-
lished in February 1992. In 1997 he resigned as Editor-in-
Chief.
After the passing away of his wife Vera in 1996, after a
restless period, he searched for new challenges and happi-
ness, which he found in 1997 in Israel, where he met Lea
Ego´zi, whom he married and lived with in Nethanya.
His main line of his research was inflammation and im-
munopharmacology. During his career, he has been (co)au-
thor of more than 225 scientific papers.
Iva´n Bonta in 1995.
During his time at Organon,
he already investigated the eﬀects
of serotonin and anti-inflamma-
tory agents in the rat paw oedema
[1, 2]. In the Erasmus University
Rotterdam, he initiated research
with isolated tissue preparations
[3, 4], performed by his first two
Ph.D. students, of whom another
twelve would follow through the
years. At that time, in the early 1970s, prostaglandins were
discovered. Their role in platelets and the rat paw model
of inflammation were the subject of a number of investiga-
tions [5–8]. After the discovery of leukotrienes, their bio-
logical activity [9] and role in inflammatory cells were in-
vestigated [10–12]. As a next step, the involvement of stim-
ulated macrophages and their substances released were in-
vestigated as tools against tumour growth [13–17]. How-
ever, not only animal and human cells were subjected to im-
munopharmacological research activities. In the 1980s, the
organ bath technique for isolated human tissue was used to
study responses of bioactive substances during inflammation
[18, 19].
Living in Israel, he initiated research on images of dis-
eases in archaic societies. He was fascinated by pre-Columbi-
an sculpted statuettes which resemble the phenomenology
of diseases. Specimens of his impressive private collection
have been shown as illustrations in a remarkable book writ-
ten by him, entitled “Diseased Ancestors: Essays and Stories
around Medical Archaeology.” In the last years, he was im-
pressed by alternative medicine [20] and associations be-
tween schizophrenia, anaesthesia, and near-death experi-
ences [21]. As a result, he wrote a paperback on this subject
in Dutch, which has just recently been published.
Iva´n had a remarkable and also a fruitful life. Through
his authorship, research, teaching, and editor’s work, he
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contributed substantially to the immunopharmacology. We
will all remember him as a person that liked to teach, to be
heard, with a vast knowledge and many stories to tell, some-
one who enjoyed being in the center of life and attention. In
general, he was a charismatic, charming, erudite, and enjoy-
able person, with a lot of very typical humour.
He is survived by his present wife Lea, his son Janos and
his wife Gladys, his daughter Zsoka and her husband Edgar,
and his three grandchildren, Peter, Ilana, and Anne.
On Sunday 11 February 2007, we buried him in the Jew-
ish cemetery in Rotterdam, next to his first wife Vera as he
wished it to be.
Freek J. Zijlstra
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